LAB Research and DMV Veterinary Centre create dedicated radiotherapy
research platform to better serve growing industry sector
Toronto Stock Exchange: LRI
LAVAL, QC, June 8 /CNW Telbec/ - LAB Research Inc. ("LAB" or "LAB Research"), (TSX: LRI), a Canadian-based global non-clinical contract research organization ("CRO"), today announced that it has completed an exclusive radiotherapy partnership with DMV Veterinary Centre ("DMV") creating a dedicated research platform.
According to the World Health Organization, it is expected that cancer will soon overtake cardiovascular diseases as a leading cause of mortality. Recent advances in the field of oncology and immunology modulators, involving a number of drug candidates in the class of biologics, have led to a new generation of approved drugs with positive safety profiles.
"The field of radiotherapy and oncology is yet another highly specialized scientific area of research in which we have established recognized leadership and expertise in the past few years. Our exclusive partnership with DMV gives us timely access to required infrastructure to support our clients research projects and allows us to successfully pursue our strategy of launching and implementing highly profitable, scientifically complex and industry differentiating services. We intend to be at the forefront of this fast growing and very promising area of scientific research over the coming years as we keep expanding our potential client audience", commented Luc Mainville, President and Chief Executive Officer of LAB Research.
"LAB Research is recognized for its scientific leadership and is the perfect partner to help us launch our new radiotherapy services" said Dr. Caroline de Jaham, Director, Professional Services of DMV Veterinary Centre.
About DMV Veterinary Centre:
The DMV Veterinary Centre is an emergency-care and medical specialties veterinary centre, serving the Greater Montreal Area. With 150 employees, DMV focuses on client service and high quality animal care, including a dozen specialists, each of them certified in his or her particular branch of veterinary medicine, treating over 15,000 cases a year from Quebec, Ontario and Northern United States.
About LAB Research Inc.:
LAB Research is a Canadian global non-clinical contract research organization that provides contract research services to the pharmaceutical, biotechnology, agro-chemical, petro-chemical and industrial markets. LAB Research supports the development of its customers' products from three state-of-the-art facilities located in Canada, Denmark and Hungary.
LAB Research's shares trade on the TSX under the symbol "LRI", with 52.7 million shares outstanding.
This news release contains certain forward-looking statements that reflect the current views and/or expectations of LAB Research Inc. with respect to its performance, business and future events. Such statements are subject to a number of risks, uncertainties and assumptions. Actual results and events may vary significantly.
SOURCE LAB RESEARCH INC.
For further information: For further information: visit LAB Research's website at www.labresearch.com, or contact: Luc Mainville, Chief Executive Officer, (450) 973-2240 (ext. 1206), email@example.com; Frédéric Dumais, Partner, Jasmin-Dumais, Financial Communications, (514) 862-1251, firstname.lastname@example.org